Bullpen.News · the best place to find stock ideas

I went through all 142 companies in Value Line this morning. Here are the 6 that made it

Six Value Line small caps including Blackbaud, Marqeta, Ranger Energy and Definitive Healthcare trade on net cash, buybacks, low multiples or a takeover bid.

BLKB $2.4BMQ $2B

Calvin Blissett 3h ago 5 clicks

4h ago ASML $616B

Deep Dive: $ASML

Rebound Capital 1 click

10h ago PBR $96B

Margin Call

Doomberg 3 clicks

From X

@Adam_Wyden Jul 12

Adam D. Wyden on X

@qlixontop @marginofdanger @RicksCEO Bmb RE worth close to 100 (assets making zero). Re held for sale I think co. said ~30. Tootsies worth 125? Ricks nyc 50? That’s 300 right there. Scarlett’s ? 50+ other clubs many are in major metro areas. This thing is worth more dead than alive now. $rick Ask @RicksCEO

@HedgeyeRetail Jul 10

Brian McGough on X

$HELE doing what it does best...Massive miss and even bigger guide down. Of course they're stripping out this huge goodwill impairment from 'adjusted EPS', which we won't do. Stock getting clocked, as it should. We've been short since over $100. CH11 is not off the table here...

@rusholmecapital Jul 9 1 click

Rusholme Capital on X

(Late) Q2'25 Update New: $META, $STN.TO, $FTT.TO, $CVG.TO, $GDI.TO, $VCI.V, $IOT.V Sold: $KNSL, $CJT.TO, $RPI.UN, $MRD.TO, $HMM.A, $FORA.TO, $THNC.TO, $BRM.V Q2: 6.6% vs 10.6% for SPX ITD (Jan '21): +165% vs +68% Fairly happy with how the portfolio is positioned 👇 https://t.co/FPQbbegoEQ

@catechwilliams Jul 7 1 click

catechwilliams on X

$INGM Massive cyber & ransomware attack. All systems over the weekend. Still can’t fulfill orders after 4 days. Customers moving to competitors (as reported on Reddit). Likely permanent damage & customer losses. Ransomware payment due. Compounded by a major IT upgrade now needed. https://t.co/kQFbwFvcLA

@Adam_Wyden Jul 1

Adam D. Wyden on X

3/ $RICK $PAR $APG $GFL $TIC

@Adam_Wyden Jul 1

Adam D. Wyden on X

1/ Odd day. Sen. passes bill on housing and RESTAURANTS. No tax on tips/ no tax on overtime pay. Powell also not ruling out cuts and restaurant stocks ripping. Overhang at $PAR has been strength of their end market / customer. Today everything got better... @SavneetS @PAR_Tech

@Adam_Wyden Jun 29

Adam D. Wyden on X

@sidecarcap $par

@MultiplesCap Jun 24

Multiples Capital on X

$EXPE has always been a much slower grower than $BKNG, won't be surprised if it's a fav pair trade of hedge fund (long booking, short expe). Over the years though Expedia has been going through internal changes, sold some businesses (Egencia to AmEx travel and few other sites), went through a technology transformation for internal sites (Expedia, https://t.co/ap3OIandej, Vrbo). 50% improvement in operating margin since 2019. But not as profitable as Booking (operating margin at 12% vs 32% for bkng). Mainly a US focused player (unlike bkng) with a very strong B2B segment that's growing mid teens and about 30% of total revenue), now looking to expand internationally. To be seen if that would drive higher margin given the much fragmented hotel market internationally vs US. Bkng on the other hand seeing revenue growth slowing down to high single digit and mid teens eps growth with margins declining since 2019. Expedia needs to show higher top line growth but possible still delivers mid teens eps growth. Travel is cyclical but these OTA are very robust, they saw revenue growth even in the financial crisis, as more ppl look for deals. AI is an unknown, Expedia is embracing it. Finding a hotel with the right deal is not same as getting an answer to a question from LLM, distribution/platform should remain valuable. Interesting to see how the pieces fall for Expedia, PEG < 1 and these multiples should atleast provide downside protection

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

Applied Materials: Buy The Engineering Powerhouse Behind AI

AMAT $301B

Dhierin Bechai 11h ago 1 click

AI Narrative Switched, Debt Yields Spike | The Weekly Wrap

CoreWeave’s rising debt yields and fading confidence in AI data-center economics frame a weekly review of Meta, Tesla, SpaceX, Netflix,…

CRWV $34BTSLA $1.5T

Steve Eisman 22h ago 21 clicks

Our Views on CoreWeave

CoreWeave's financial statements point to a business model familiar to the authors after a closer review of the AI infrastructure company.

CRWV $34B

WHAT ARE WE DOING? “Contrarians At The Gate” 31h ago 10 clicks

DigitalOcean's AI Flywheel: Unleashing Massive Growth Potential For Bold Investors

DOCN $12B

Star Investments 22h ago 6 clicks

Bloom Energy (NYSE: BE) Q3 FY12/26 Earnings - Revenue Up 138% On The Datacenter Power Race

Bloom Energy’s Q3 FY26 revenue rose 138% to $1.24 billion as datacenter power orders lifted operating margin to 18%; capex drove $181…

BE $56B

Cestrian Capital Research 23h ago 5 clicks

Philip Morris: Taking the Fight to the U.S.

Philip Morris reported Q3 growth across heated tobacco, combustibles and e-vapor in Europe while gaining U.S. nicotine-pouch share.

PM $314B

Librarian Capital's Research Library 23h ago 1 click

Amazon’s Trainium Takes a Strike at the Training King

Amazon’s Trainium3 adds native PyTorch training support, targeting CUDA-trained researchers with standard APIs, eager mode and…

AMZN $2.8T

SemiAnalysis 23h ago 6 clicks

Alphabet: Gemini 4 Argon Is Coming For ChatGPT's Lunch

Alphabet's Gemini 4 Argon aims to undercut rival AI models using proprietary TPUs, while Android, Siri and Google Cloud distribution…

GOOGL $3.9T

Dustin Quasney 26h ago 2 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $34B

Net Interest 26h ago 7 clicks

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $108B

MBI Deep Dives 27h ago 1 click

Big Tech Will Spend More on AI This Year Than Walmart Sells

Alphabet, Amazon, Meta and Microsoft plan nearly $800 billion of AI infrastructure spending, testing whether incremental returns can stay…

GOOGL $3.9TMSFT $3.9T

Ezra's Notes 27h ago 3 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $11B

TSOH Investment Research 27h ago 3 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $260B

Cestrian Capital Research 28h ago 5 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

TEM $11BMRNA $98B

Edmund Ingham 30h ago 3 clicks

Research & Analysis: ERock, Inc. (NYSE: EROC)

ERock’s modular microgrids bridge data-center power gaps years before grid interconnects, with Meta and Anthropic projects filling capacity…

EROC $453M

Monte Independent Investment Research 31h ago 7 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B

Best Anchor Stocks 32h ago 11 clicks

Lockheed Martin Q3 FY12/26 Earnings Review

Lockheed Martin's Q3 missile sales rose 24% on PAC-3, THAAD, GMLRS and PrSM ramps, lifting Missiles and Fire Control backlog to $142.5…

LMT $127B

Cestrian Capital Research 33h ago 4 clicks

Industry Primers Podcast: Natural Resources Royalty & Streaming, Part One: The Story

Franco-Nevada, Wheaton and Texas Pacific Land built royalty and streaming businesses by buying fixed shares of mines and wells, tracing the…

FNV $47BWPM $57B

Latticework by MOI Global 34h ago 3 clicks

Oscar Health: Up Over 200% From The March Lows, Still Room To Run (Ticker: OSCR)

Oscar Health raised 2026 operating earnings guidance to $600 million-$800 million after ACA-marketplace expansion drove 60% membership and…

OSCR $10B

Emerging Moats Research 36h ago 4 clicks

PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $103M

Value Investors Club Jul 25

Latest News

Adam D. Wyden on X

Brian McGough on X

Rusholme Capital on X

catechwilliams on X

Adam D. Wyden on X

Adam D. Wyden on X

Adam D. Wyden on X

Multiples Capital on X

Investor Letters

Recent recaps

Latest recap

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 56 of 248

X accounts we follow

Investor letters we follow

Sectors